AbbVie grant requests originating from the United States and Puerto Rico are managed by a centralized grant department and more information is available at grants.abbvie.com.
AbbVie discloses donations and grants made by the company because we are committed to sharing our commitment to promote health education and charitable causes that ultimately benefit patients.
The list of AbbVie’s grants and contributions are provided in the annual report below. AbbVie’s report reflects educational grants, patient support, charitable donations, as well as fellowships and scholarships. The report includes individual direct payments of more than $200 from AbbVie’s US and Puerto Rico businesses.
Annual Report
AbbVie officially became a company January 1, 2013. In May 2020, AbbVie completed the acquisition of Allergan and began operating as a combined company.
Unless otherwise specified, all product names appearing in this internet site are trademarks owned by or licensed to AbbVie Inc., its subsidiaries or affiliates. No use of any AbbVie trademark, trade name, or trade dress in this site may be made without the prior written authorization of AbbVie Inc., except to identify the product or services of the company.
Copyright © 2026 AbbVie Inc. North Chicago, Illinois, U.S.A.
The product-specific site Internet site that you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals that are not approved in other countries or region. If you are a resident of a country other than those to which the site is directed, please return to AbbVie.com or contact your local AbbVie affiliate to obtain the appropriate product information for your country of residence. The Internet site that you have requested may not be optimized to your screen size. Do you wish to continue to this product-specific site?